<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Child Adolesc Psychopharmacol</journal-id><journal-id journal-id-type="iso-abbrev">J Child Adolesc Psychopharmacol</journal-id><journal-id journal-id-type="pmc-domain-id">1148</journal-id><journal-id journal-id-type="pmc-domain">cap</journal-id><journal-id journal-id-type="publisher-id">cap</journal-id><journal-title-group><journal-title>Journal of Child and Adolescent Psychopharmacology</journal-title></journal-title-group><issn pub-type="ppub">1044-5463</issn><issn pub-type="epub">1557-8992</issn><publisher><publisher-name>Mary Ann Liebert, Inc.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11238837</article-id><article-id pub-id-type="pmcid-ver">PMC11238837.1</article-id><article-id pub-id-type="pmcaid">11238837</article-id><article-id pub-id-type="pmcaiid">11238837</article-id><article-id pub-id-type="pmid">38700276</article-id><article-id pub-id-type="doi">10.1089/cap.2024.0018</article-id><article-id pub-id-type="publisher-id">10.1089/cap.2024.0018</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review Articles</subject></subj-group></article-categories><title-group><article-title>Short- and Long-Term Outcomes of Suboptimal Medication Adherence in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Systematic Literature Review</article-title><alt-title alt-title-type="left-running-head">ABDALLAH ET AL.</alt-title><alt-title alt-title-type="right-running-head">OUTCOMES OF SUBOPTIMAL MEDICATION ADHERENCE IN ADHD</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Abdallah</surname><given-names initials="S">Salayna</given-names></name><degrees>BS</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0009-4809-1988</contrib-id></contrib><contrib contrib-type="author"><name name-style="western"><surname>Church</surname><given-names initials="E">Emma</given-names></name><degrees>BA</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Levin</surname><given-names initials="JB">Jennifer B.</given-names></name><degrees>PhD</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chela</surname><given-names initials="A">Amarpreet</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>McVoy</surname><given-names initials="M">Molly</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="corr1" ref-type="corresp"/><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4967-6055</contrib-id></contrib><aff id="aff1"><label><sup>1</sup></label>Department of Psychiatry, University Hospitals of Cleveland Medical Center, Cleveland, Ohio, USA.</aff><aff id="aff2"><label><sup>2</sup></label>Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.</aff><aff id="aff3"><label><sup>3</sup></label>Department of Psychology, Cleveland State University, Cleveland, Ohio, USA.</aff></contrib-group><author-notes><corresp id="corr1">Address correspondence to: Molly McVoy, MD, University Hospitals Cleveland Medical Ctr., Department of Psychiatry. 10524 Euclid Ave., Cleveland, OH 44106, USA <email>Molly.McVoy@UHhospitals.org</email></corresp><fn fn-type="fn"><p><sup>i</sup>ORCID ID (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0009-0009-4809-1988" ext-link-type="uri">https://orcid.org/0009-0009-4809-1988</ext-link>).</p></fn><fn fn-type="fn"><p><sup>ii</sup>ORCID ID (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0003-4967-6055" ext-link-type="uri">https://orcid.org/0000-0003-4967-6055</ext-link>).</p></fn><fn id="fn3" fn-type="other"><p><bold>Funding Information:</bold> The Case Western Reserve University (CWRU) Center for Excellence/NIDA/NIH Customized Adherence Intervention for Adolescents and Young Adults with Attention Deficit Hyperactivity Disorder (ADHD). The National Institutes of Health (NIH) and National Institute on Drug Abuse (NIDA) grant number is as follows: 1 P30 DA054557.</p></fn></author-notes><pub-date pub-type="collection"><month>5</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>23</day><month>5</month><year>2024</year></pub-date><volume>34</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">466613</issue-id><fpage>183</fpage><lpage>193</lpage><pub-history><event event-type="pmc-release"><date><day>23</day><month>05</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>23</day><month>05</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-05-23 00:25:25.033"><day>23</day><month>05</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright 2024, Mary Ann Liebert, Inc., publishers</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Mary Ann Liebert, Inc., publishers</copyright-holder></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="cap.2024.0018.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="cap.2024.0018.pdf"/><abstract><sec id="S017"><title>Introduction:</title><p>Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition with severe and life-long consequences. Adolescents and young adults represent a particularly vulnerable subgroup because of the unique demands of their developmental stage. Despite the well-known efficacy of medication treatment for ADHD, there remains a notable concern regarding poor medication adherence in this population.</p></sec><sec id="S018"><title>Objectives:</title><p>This systematic literature review aimed to synthesize the existing empirical evidence on the outcomes and consequences of medication nonadherence among adolescents and young adults with ADHD.</p></sec><sec id="S019"><title>Methods:</title><p>An extensive database search was conducted on September 26, 2022, with no time limits applied. The databases included Scopus, PubMed, CINAHL, Cochrane, and PsycINFO.</p></sec><sec id="S020"><title>Results:</title><p>Six studies met the inclusion criteria. Each study revealed that medication nonadherence was associated with a range of adverse outcomes, including decreased academic performance, heightened familial, and psychological stress, and an increased likelihood of substance use, pregnancy, obesity, and injury. Conversely, adherence led to improvements in at least one ADHD-related outcome.</p></sec><sec id="S021"><title>Conclusions:</title><p>Research exploring the consequences of suboptimal medication adherence in adolescents and young adults with ADHD is currently limited, and effective strategies to address this issue remain scarce. A thorough understanding of such consequences is critical for developing interventions aimed at improving medication adherence and mitigating the risk of adverse outcomes, especially considering the susceptibility of this population.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>attention-deficit/hyperactivity disorder</kwd><kwd>medication adherence</kwd><kwd>nonadherence</kwd><kwd>adolescents and young adults</kwd><kwd>consequences</kwd></kwd-group><counts><fig-count count="1"/><table-count count="2"/><equation-count count="00"/><ref-count count="41"/><page-count count="11"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>